In MLex, White & Case partner Anna Kertesz is quoted about the Federal Trade Commission's (FTC) pharmaceutical merger review process and what the FTC considers when investigating pharmaceutical pipeline product overlaps. Drug makers Amgen Inc.'s and Horizon Therapeutics's proposed transaction ...
Horizon Therapeutics06-Oct-2023Merger/AcquisitionPharmaceuticals Generate:Biomedicines06-Sep-2023Later Stage VCBiotechnology Chemocentryx20-Oct-2022Merger/AcquisitionPharmaceuticals You’re viewing 5 of 70 investments and acquisitions. Get the full list » ...
US sues to block drug merger Ukraine says it has blocked an unprecedented barrage of Russian missiles over Kyiv FTC warns of ‘rampant’ pharma consolidation as it targets $28bn Amgen deal US regulator sues to block takeover of biotech group Horizon Therapeutics ...
The Federal Trade Commission reached a proposed consent order with Amgen Inc. to address the potential competitive harm that would result from Amgen’s $27.8 billion acquisition of Horizon Therapeutics plc. As part of a nationwide settlement of their chal...
Reverse Merger Subscribe to see more $XXM Subscribe to see more 10 2/1/2016 Divestiture Subscribe to see more $XXM Subscribe to see more 10 AmgenAcquisitions 26 Acquisitions Amgenacquired26companies. Their latest acquisition wasHorizon TherapeuticsonOctober 06, 2023. ...